Current reports
Up-to-date announcements resulting from information obligations of listed companies.
Current reports published before January 1, 2024 are available on the Polish section:
| Report | Details | Publication | Action |
|---|---|---|---|
| ESPI Report 34/2024 |
Notification of transactions executed by a person discharging managerial responsibilities |
14.08.2024 | Read more |
| ESPI Report 33/2024 |
Annex to the distribution agreement with Intuitive Surgical Sarl |
01.08.2024 | Read more |
| ESPI Report 32/2024 |
Information on the conclusion of a significant agreement |
26.07.2024 | Read more |
| ESPI Report 31/2024 |
Operational highlights of the medical devices, IT solutions and services sales segment |
08.07.2024 | Read more |
| ESPI Report 30/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
13.06.2024 | Read more |
| ESPI Report 29/2024 |
Information on the conclusion of a significant sales agreement |
03.06.2024 | Read more |
| ESPI Report 28/2024 |
Information on the conclusion of a significant agreement |
24.05.2024 | Read more |
| ESPI Report 27/2024 |
Partnership agreement for exclusive distribution of Symani microsurgery robots |
22.05.2024 | Read more |
| ESPI Report 26/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
17.05.2024 | Read more |
| ESPI Report 25/2024 |
Information on the conclusion of a significant agreement |
06.05.2024 | Read more |
| ESPI Report 24/2024 |
Contract for the exclusive distribution of Qure.ai’s global artificial intelligence solution to assess the results of radiology tests in Poland, the Czech Republic and Slovakia |
19.04.2024 | Read more |
| ESPI Report 23/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
18.04.2024 | Read more |
| ESPI Report 22/2024 |
Operational highlights of the medical devices, IT solutions and services sales segment |
10.04.2024 | Read more |
| ESPI Report 21/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
09.04.2024 | Read more |
| ESPI Report 20/2024 |
Information on the conclusion of a significant sales agreement |
28.03.2024 | Read more |
| ESPI Report 19/2024 |
Notification of transactions executed by a person discharging managerial responsibilities |
12.03.2024 | Read more |
| ESPI Report 18/2024 |
Information on the conclusion of a significant sales agreement |
08.03.2024 | Read more |
| ESPI Report 17/2024 |
List of shareholders holding at least 5% of the total number of votes at the Ordinary Shareholder Meeting on 26 February 2024 |
27.02.2024 | Read more |
| ESPI Report 16/2024 |
Resolutions adopted by the Ordinary Shareholder Meeting of Synektik SA on 26 February 2024 |
27.02.2024 | Read more |
| ESPI Report 15/2024 |
Dividend payout resolution |
26.02.2024 | Read more |
| ESPI Report 14/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
26.02.2024 | Read more |
| ESPI Report 13/2024 |
Notification of transactions executed by a person discharging managerial responsibilities |
23.02.2024 | Read more |
| ESPI Report 12/2024 |
Information on the conclusion of a significant sales agreement |
22.02.2024 | Read more |
| ESPI Report 11/2024 |
Expansion of a cooperation agreement |
22.02.2024 | Read more |
| ESPI Report 10/2024 |
Notification of transactions executed by a person discharging managerial responsibilities |
21.02.2024 | Read more |
| ESPI Report 9/2024 |
Information on the conclusion of a significant agreement on the sale of a robotic system |
19.02.2024 | Read more |
| ESPI Report 8/2024 |
Estimated revenue in Q1 2023 |
31.01.2024 | Read more |
| ESPI Report 7/2024 |
Obtaining a patent for a cardiac marker in Japan |
25.01.2024 | Read more |
| Appendix 2 – ESPI Report 6/2024 |
Auditor's assessment of Synektik's report on payments of the Management Board and Supervisory Board for FY2022 |
25.01.2024 | Read more |
| Appendix 1 – ESPI Report 6/2024 |
Report on payments of the Management Board and Supervisory Board for FY2022 |
25.01.2024 | Read more |
| ESPI Report 6/2024 |
Completion of documentation to be discussed at the Ordinary General Meeting of SYNEKTIK SA |
25.01.2024 | Read more |
| Appendix – ESPI Report 5/2024/K |
Corrected draft resolutions attached to ESPI report 5/2024/K |
22.01.2024 | Read more |
| ESPI Report 5/2024/K |
Correction of current report ESPI 5/2024 - Announcement on convening the Ordinary General Meeting of Shareholders for February 26, 2024 |
22.01.2024 | Read more |
| Appendixes – ESPI Report 5/2024 | 22.01.2024 | Read more | |
| ESPI Report 5/2024 |
Announcement on the convening of the Ordinary General Meeting of Shareholders for February 26, 2024 |
22.01.2024 | Read more |
| ESPI Report 4/2024 |
Recommendation of the Management Board on the payment of dividends for FY2022 |
19.01.2024 | Read more |
| ESPI Report 3/2024 |
Establishment of a bank guarantee for a counterparty |
17.01.2024 | Read more |
| ESPI Report 2/2024 |
Update on the cardiotracer project |
10.01.2024 | Read more |
| ESPI Report 1/2024 |
Selected operating data of the medical devices, IT solutions and services sales segment |
08.01.2024 | Read more |